Crizanlizumab, sold under the brand name Adakveo among others, is a monoclonal antibody medication that binds to P-selectin. It is a medication used to...
12 KB (856 words) - 11:43, 12 December 2023
B06AC04 Conestat alfa B06AC05 Lanadelumab B06AC06 Berotralstat B06AX01 Crizanlizumab B06AX02 Betibeglogene autotemcel B06AX03 Voxelotor B06AX04 Mitapivat...
960 bytes (213 words) - 02:49, 18 December 2023
route, amount and type of fluid replacement remains uncertain. In 2019, Crizanlizumab, a monoclonal antibody target towards p-selectin was approved in the...
141 KB (15,222 words) - 11:55, 12 August 2024
crilvastatin (INN) Crinone crisaborole crisnatol (INN) Criticare HN Crixivan Crizanlizumab-tmca crizotinib (USAN), INN) croconazole (INN) CroFab Crofelemer crolibulin...
7 KB (417 words) - 00:11, 9 August 2024
attaches to its target. An example of a humanized monoclonal antibody is crizanlizumab, which treats sickle cell disease. Human monoclonal antibodies are identified...
20 KB (2,374 words) - 10:03, 20 December 2023
Atezolizumab Benralizumab Camrelizumab† Cedelizumab Certolizumab pegol Crizanlizumab Daclizumab Eculizumab Efalizumab‡ Epratuzumab Erlizumab Etrolizumab†...
38 KB (4,304 words) - 10:14, 21 July 2024
Pharmaceuticals cystic fibrosis Zanubrutinib BeiGene mantle cell lymphoma Crizanlizumab-tmca Novartis sickle cell disease Givosiran Alnylam Pharmaceuticals...
34 KB (180 words) - 22:09, 8 April 2024
Crenezumab mab humanized β-amyloid (1-40 and 1-42) Alzheimer's disease Crizanlizumab Adakveo mab humanized selectin P Y sickle-cell disease Crotedumab mab...
136 KB (4,020 words) - 07:14, 15 August 2024
and endothelial cell is significant for blocking tumor dissemination. Crizanlizumab is a monoclonal antibody against P-selectin. which has now been approved...
20 KB (2,579 words) - 01:43, 27 December 2023
Dietary supplementation of folic acid is recommended by the WHO. In 2019, Crizanlizumab, a monoclonal antibody was approved by the United States FDA for reducing...
32 KB (3,700 words) - 04:56, 23 July 2024
Atezolizumab Benralizumab Camrelizumab† Cedelizumab Certolizumab pegol Crizanlizumab Daclizumab Eculizumab Efalizumab‡ Epratuzumab Erlizumab Etrolizumab†...
2 KB (87 words) - 01:28, 30 May 2023
University of Pennsylvania (Penn Medicine), initiated a clinical trial of crizanlizumab for RVCL. Miner also established a large RVCL Research Center, which...
17 KB (1,801 words) - 06:00, 24 June 2024
needed] "Global Novartis News Archive". "New Novartis medicine Adakveo (Crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living...
10 KB (1,034 words) - 03:31, 9 February 2024